Daniel Wintner Goodman is Director of Tonix Pharmaceuticals Holding Corp.. Currently has a direct ownership of 5,001 shares of TNXP, which is worth approximately $650. The most recent transaction as insider was on May 25, 2021, when has been sold 5,000 shares (Common Stock) at a price of $1.12 per share, resulting in proceeds of $5,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $650

Daniel Wintner Goodman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2021
BUY
Open market or private purchase
$5,600 $1.12 p/Share
5,000 Added 50.0%
5,001 Common Stock
DWG

Daniel Wintner Goodman

Director
Chatham, NJ

Track Institutional and Insider Activities on TNXP

Follow Tonix Pharmaceuticals Holding Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNXP shares.

Notify only if

Insider Trading

Get notified when an Tonix Pharmaceuticals Holding Corp. insider buys or sells TNXP shares.

Notify only if

News

Receive news related to Tonix Pharmaceuticals Holding Corp.

Track Activities on TNXP